|
TRMT6 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.638680E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.69739999999719E-05 |
| Normal-vs-Stage2 |
1.834360E-04 |
| Normal-vs-Stage3 |
1.777240E-01 |
| Normal-vs-Stage4 |
2.252500E-02 |
| Stage1-vs-Stage2 |
2.273000E-01 |
| Stage1-vs-Stage3 |
2.402200E-01 |
| Stage1-vs-Stage4 |
9.403200E-01 |
| Stage2-vs-Stage3 |
6.444400E-02 |
| Stage2-vs-Stage4 |
4.223800E-01 |
| Stage3-vs-Stage4 |
4.467600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.774400E-04 |
| Normal-vs-AfricanAmerican |
1.217440E-04 |
| Normal-vs-Asian |
2.907600E-01 |
| Caucasian-vs-AfricanAmerican |
7.163800E-01 |
| Caucasian-vs-Asian |
5.464000E-01 |
| AfricanAmerican-vs-Asian |
3.645400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.24819999949943E-07 |
| Normal-vs-Female |
2.391600E-01 |
| Male-vs-Female |
2.847700E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.617200E-03 |
| Normal-vs-Extreme_Weight |
1.81845999999153E-05 |
| Normal-vs-Obese |
4.798600E-03 |
| Normal-vs-Extreme_Obese |
9.610100E-04 |
| Normal_Weight-vs-Extreme_Weight |
4.174000E-01 |
| Normal_Weight-vs-Obese |
7.635600E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.350600E-01 |
| Extreme_Weight-vs-Obese |
2.138600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.785000E-01 |
| Obese-vs-Extreme_Obese |
1.874250E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.514400E-01 |
| Normal-vs-Age(41-60Yrs) |
7.777600E-03 |
| Normal-vs-Age(61-80Yrs) |
2.31429999997257E-06 |
| Normal-vs-Age(81-100Yrs) |
9.59510000000385E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.459600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.245400E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.364300E-04 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.463520E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.987590E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.197980E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.6828999999965E-05 |
| Normal-VS-Type2 PRCC |
2.41840000025917E-07 |
| Normal-VS-KIRP CIMP |
7.003600E-01 |
| Normal-VS-Unclassified PRCC |
9.090000E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.217750E-02 |
| Type1 PRCC-VS-KIRP CIMP |
4.441100E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
3.962600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.207530E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
4.348300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.758400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.42289999999412E-06 |
| Normal-vs-N1 |
6.836600E-01 |
| Normal-vs-N2 |
1.023600E-01 |
| N0-vs-N1 |
9.059600E-03 |
| N0-vs-N2 |
7.136600E-01 |
| N1-vs-N2 |
3.468000E-01 |
|
|
